Tarsus Pharmaceuticals Inc (TARS) support and resistance · rev $336.0M
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
This page maps Tarsus Pharmaceuticals Inc (TARS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
TARS currently screens at market cap $2.66B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TARS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TARS quote page for the session range and the stock page for the full model.
Not investment advice.